ADAGIO MEDICAL HOLDINGS INC (ADGM) Stock Price & Overview
NASDAQ:ADGM • US00534B1008
Current stock price
The current stock price of ADGM is 1.25 USD. Today ADGM is up by 6.84%. In the past month the price increased by 28.88%. In the past year, price increased by 68.76%.
ADGM Key Statistics
- Market Cap
- 26.475M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.75
- Dividend Yield
- N/A
ADGM Stock Performance
ADGM Stock Chart
ADGM Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ADGM. When comparing the yearly performance of all stocks, ADGM is one of the better performing stocks in the market, outperforming 87.31% of all stocks.
ADGM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ADGM. Both the profitability and financial health of ADGM have multiple concerns.
ADGM Earnings
ADGM Forecast & Estimates
7 analysts have analysed ADGM and the average price target is 4.08 USD. This implies a price increase of 226.4% is expected in the next year compared to the current price of 1.25.
For the next year, analysts expect an EPS growth of 65.5% and a revenue growth -100% for ADGM
ADGM Groups
Sector & Classification
ADGM Financial Highlights
Over the last trailing twelve months ADGM reported a non-GAAP Earnings per Share(EPS) of -4.75. The EPS decreased by -229.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -250.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ADGM Ownership
ADGM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ADGM
Company Profile
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.
Company Info
IPO: 2021-02-26
ADAGIO MEDICAL HOLDINGS INC
26051 Merit Circle, Suite 102
Laguna Hills CALIFORNIA US
Employees: 80
Phone: 19493481188
ADAGIO MEDICAL HOLDINGS INC / ADGM FAQ
What does ADAGIO MEDICAL HOLDINGS INC do?
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.
Can you provide the latest stock price for ADAGIO MEDICAL HOLDINGS INC?
The current stock price of ADGM is 1.25 USD. The price increased by 6.84% in the last trading session.
Does ADAGIO MEDICAL HOLDINGS INC pay dividends?
ADGM does not pay a dividend.
How is the ChartMill rating for ADAGIO MEDICAL HOLDINGS INC?
ADGM has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the growth outlook for ADAGIO MEDICAL HOLDINGS INC?
The Revenue of ADAGIO MEDICAL HOLDINGS INC (ADGM) is expected to decline by -100% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for ADGM stock?
ADAGIO MEDICAL HOLDINGS INC (ADGM) will report earnings on 2026-04-06.
Can you provide the short interest for ADGM stock?
The outstanding short interest for ADAGIO MEDICAL HOLDINGS INC (ADGM) is 0.14% of its float.